• 2023
  Lefèvre S, Njamkepo E, Feldman S, Ruckly C, Carle I, Lejay-Collin M, Fabre L, Yassine I, Frézal L, Pardos de la Gandara M, Fontanet A, Weill FX, Rapid emergence of extensively drug-resistant Shigella sonnei in France., Nat Commun 2023 Jan; 14(1): 462.
• 2022
  Grant R, Flechelles O, Elenga N, Tressières B, Gaete S, Hebert JC, Schaub B, Djossou F, Mallard A, Delver L, Ryan C, Funk AL, Cabié A, Fontanet A, Hoen B, Consequences of In Utero Zika Virus Exposure and Adverse Pregnancy and Early Childhood Outcomes: A Prospective Cohort Study., Viruses 2022 Dec; 14(12): .
• 2022
  Bruel T, Pinaud L, Tondeur L, Planas D, Staropoli I, Porrot F, Guivel-Benhassine F, Attia M, Pelleau S, Woudenberg T, Duru C, Koffi AD, Castelain S, Fernandes-Pellerin S, Jolly N, De Facci LP, Roux E, Ungeheuer MN, Van Der Werf S, White M, Schwartz O, Fontanet A, , Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study., EClinicalMedicine 2022 Sep; 51(): 101576.
• 2022
  Ramassamy JL, Ndongo CB, Nnuka P, Antunes M, Mener ML, A Betsem EB, Njouom R, Cassar O, Fontanet A, Gessain A, , Epidemiological evidence of nosocomial and zoonotic transmission of HTLV-1 in a large survey in rural population of central Africa., J Infect Dis 2022 Jul; (): .
• 2022
  Colosi E, Bassignana G, Contreras DA, Poirier C, Boëlle PY, Cauchemez S, Yazdanpanah Y, Lina B, Fontanet A, Barrat A, Colizza V, , Screening and vaccination against COVID-19 to minimise school closure: a modelling study., Lancet Infect Dis 2022 Apr; (): .
• 2022
  Grant R, Charmet T, Schaeffer L, Galmiche S, Madec Y, Von Platen C, Chény O, Omar F, David C, Rogoff A, Paireau J, Cauchemez S, Carrat F, Septfons A, Levy-Bruhl D, Mailles A, Fontanet A, , Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: Results from a nationwide case-control study in France., Lancet Reg Health Eur 2022 Feb; 13(): 100278.
• 2022
  Bosetti P, Tran Kiem C, Andronico A, Colizza V, Yazdanpanah Y, Fontanet A, Benamouzig D, Cauchemez S, , Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to France., BMC Med 2022 01; 20(1): 33.
• 2022
  Bosetti P, Tran Kiem C, Andronico A, Paireau J, Levy-Bruhl D, Alter L, Fontanet A, Cauchemez S, , Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22., Euro Surveill 2022 01; 27(1): .
• 2022
  Oliu-Barton M, Pradelski BSR, Algan Y, Baker MG, Binagwaho A, Dore GJ, El-Mohandes A, Fontanet A, Peichl A, Priesemann V, Wolff GB, Yamey G, Lazarus JV, , Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines., Lancet Glob Health 2022 01; 10(1): e142-e147.
• 2021
  Tran Kiem C, Bosetti P, Paireau J, Crépey P, Salje H, Lefrancq N, Fontanet A, Benamouzig D, Boëlle PY, Desenclos JC, Opatowski L, Cauchemez S, , SARS-CoV-2 transmission across age groups in France and implications for control., Nat Commun 2021 11; 12(1): 6895.
• 2021
  Pelleau S, Woudenberg T, Rosado J, Donnadieu F, Garcia L, Obadia T, Gardais S, Elgharbawy Y, Velay A, Gonzalez M, Nizou JY, Khelil N, Zannis K, Cockram C, Merkling SH, Meola A, Kerneis S, Terrier B, de Seze J, Planas D, Schwartz O, Dejardin F, Petres S, von Platen C, Pellerin SF, Arowas L, de Facci LP, Duffy D, Cheallaigh CN, Dunne J, Conlon N, Townsend L, Duong V, Auerswald H, Pinaud L, Tondeur L, Backovic M, Hoen B, Fontanet A, Mueller I, Fafi-Kremer S, Bruel T, White M, , Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection., J Infect Dis 2021 11; 224(9): 1489-1499.
• 2021
  Lefèvre B, Tondeur L, Madec Y, Grant R, Lina B, van der Werf S, Rabaud C, Fontanet A, , Beta SARS-CoV-2 variant and BNT162b2 vaccine effectiveness in long-term care facilities in France., Lancet Healthy Longev 2021 Nov; 2(11): e685-e687.
• 2021
  Grzelak L, Velay A, Madec Y, Gallais F, Staropoli I, Schmidt-Mutter C, Wendling MJ, Meyer N, Planchais C, Rey D, Mouquet H, Reix N, Glady L, Hansmann Y, Bruel T, De Sèze J, Fontanet A, Gonzalez M, Schwartz O, Fafi-Kremer S, , Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2., J Infect Dis 2021 09; 224(6): 983-988.
• 2021
  Charmet T, Schaeffer L, Grant R, Galmiche S, Chény O, Von Platen C, Maurizot A, Rogoff A, Omar F, David C, Septfons A, Cauchemez S, Gaymard A, Lina B, Lefrancois LH, Enouf V, van der Werf S, Mailles A, Levy-Bruhl D, Carrat F, Fontanet A, , Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France., Lancet Reg Health Eur 2021 Sep; 8(): 100171.
• 2021
  Gallais F, Gantner P, Bruel T, Velay A, Planas D, Wendling MJ, Bayer S, Solis M, Laugel E, Reix N, Schneider A, Glady L, Panaget B, Collongues N, Partisani M, Lessinger JM, Fontanet A, Rey D, Hansmann Y, Kling-Pillitteri L, Schwartz O, De Sèze J, Meyer N, Gonzalez M, Schmidt-Mutter C, Fafi-Kremer S, , Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection., EBioMedicine 2021 Sep; 71(): 103561.
• 2021
  Galmiche S, Charmet T, Schaeffer L, Paireau J, Grant R, Chény O, Von Platen C, Maurizot A, Blanc C, Dinis A, Martin S, Omar F, David C, Septfons A, Cauchemez S, Carrat F, Mailles A, Levy-Bruhl D, Fontanet A, , Exposures associated with SARS-CoV-2 infection in France: A nationwide online case-control study., Lancet Reg Health Eur 2021 Aug; 7(): 100148.
• 2021
  Tran Kiem C, Massonnaud CR, Levy-Bruhl D, Poletto C, Colizza V, Bosetti P, Fontanet A, Gabet A, Olié V, Zanetti L, Boëlle PY, Crépey P, Cauchemez S, , A modelling study investigating short and medium-term challenges for COVID-19 vaccination: From prioritisation to the relaxation of measures., EClinicalMedicine 2021 Aug; 38(): 101001.
• 2021
  Cauchemez S, Bosetti P, Kiem CT, Mouro V, Consoli A, Fontanet A, , Education and mental health: good reasons to vaccinate children., Lancet 2021 07; 398(10298): 387.
• 2021
  Woudenberg T, Pelleau S, Anna F, Attia M, Donnadieu F, Gravet A, Lohmann C, Seraphin H, Guiheneuf R, Delamare C, Stefic K, Marlet J, Brochot E, Castelain S, Augereau O, Sibilia J, Dubos F, Meddour D, Guen CG, Coste-Burel M, Imbert-Marcille BM, Chauvire-Drouard A, Schweitzer C, Gatin A, Lomazzi S, Joulié A, Haas H, Cantais A, Bertholon F, Chinazzo-Vigouroux MF, Abdallah MS, Arowas L, Charneau P, Hoen B, Demeret C, Werf SV, Fontanet A, White M, , Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France., EBioMedicine 2021 Aug; 70(): 103495.
• 2021
  Tran Kiem C, Andronico A, Bosetti P, Paireau J, Alter L, Boëlle PY, Fontanet A, Lévy-Bruhl D, Cauchemez S, , Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021., Euro Surveill 2021 07; 26(26): .
• 2021
  Berthet N, Descorps-Declère S, Besombes C, Curaudeau M, Nkili Meyong AA, Selekon B, Labouba I, Gonofio EC, Ouilibona RS, Simo Tchetgna HD, Feher M, Fontanet A, Kazanji M, Manuguerra JC, Hassanin A, Gessain A, Nakoune E, , Genomic history of human monkey pox infections in the Central African Republic between 2001 and 2018., Sci Rep 2021 06; 11(1): 13085.
• 2021
  Landier J, Paireau J, Rebaudet S, Legendre E, Lehot L, Fontanet A, Cauchemez S, Gaudart J, , Cold and dry winter conditions are associated with greater SARS-CoV-2 transmission at regional level in western countries during the first epidemic wave., Sci Rep 2021 06; 11(1): 12756.
• 2021
  Moutchia J, Njouom R, Rumpler E, Besombes C, Texier G, Tejiokem M, Crépey P, Fontanet A, Shimakawa Y, , Maternal Age at First Childbirth and Geographical Variation in Hepatitis B Virus Prevalence in Cameroon: Important Role of Mother-to-Child Transmission., Clin Infect Dis 2022 Mar; 74(5): 836-845.
• 2021
  Grant R, Nguyen TTT, Dao MH, Pham HTT, Piorkowski G, Pham TDT, Cao TM, Huynh LTK, Nguyen QH, Vien LDK, Lemoine F, Zhukova A, Hoang DTN, Nguyen HT, Nguyen NT, Le LB, Ngo MNQ, Tran TC, Le NNT, Nguyen MN, Pham HT, Hoang TTD, Dang TV, Vu AT, Nguyen QNT, de Lamballerie X, Pham QD, Luong QC, Fontanet A, , Maternal and neonatal outcomes related to Zika virus in pregnant women in Southern Vietnam: An epidemiological and virological prospective analysis., Lancet Reg Health West Pac 2021 Jun; 11(): 100163.
• 2021
  Dufloo J, Grzelak L, Staropoli I, Madec Y, Tondeur L, Anna F, Pelleau S, Wiedemann A, Planchais C, Buchrieser J, Robinot R, Ungeheuer MN, Mouquet H, Charneau P, White M, Lévy Y, Hoen B, Fontanet A, Schwartz O, Bruel T, , Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies., Cell Rep Med 2021 05; 2(5): 100275.
• 2021
  Fontanet A, Tondeur L, Grant R, Temmam S, Madec Y, Bigot T, Grzelak L, Cailleau I, Besombes C, Ungeheuer MN, Renaudat C, Perlaza BL, Arowas L, Jolly N, Pellerin SF, Kuhmel L, Staropoli I, Huon C, Chen KY, Crescenzo-Chaigne B, Munier S, Charneau P, Demeret C, Bruel T, Eloit M, Schwartz O, Hoen B, , SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020., Euro Surveill 2021 04; 26(15): .
• 2021
  Grant R, Dub T, Andrianou X, Nohynek H, Wilder-Smith A, Pezzotti P, Fontanet A, , SARS-CoV-2 population-based seroprevalence studies in Europe: a scoping review., BMJ Open 2021 04; 11(4): e045425.
• 2021
  Parize P, Sommé J, Schaeffer L, Ribadeau-Dumas F, Benabdelkader S, Durand A, Tarantola A, Cailhol J, Goesch J, Kergoat L, Le Guern AS, Mousel ML, Dacheux L, Consigny PH, Fontanet A, Francuz B, Bourhy H, , Systematic Booster after Rabies Pre-Exposure Prophylaxis to Alleviate Rabies Antibody Monitoring in Individuals at Risk of Occupational Exposure., Vaccines (Basel) 2021 Mar; 9(4): .
• 2021
  Shen S, Xiao W, Zhang L, Lu J, Funk A, He J, Tu S, Yu J, Yang L, Fontanet A, Bao W, Cheng KK, Qiu X, , Prevalence of congenital microcephaly and its risk factors in an area at risk of Zika outbreaks., BMC Pregnancy Childbirth 2021 Mar; 21(1): 214.
• 2021
  Fontanet A, Autran B, Lina B, Kieny MP, Karim SSA, Sridhar D, , SARS-CoV-2 variants and ending the COVID-19 pandemic., Lancet 2021 03; 397(10278): 952-954.
• 2021
  Denis F, Fontanet A, Le Douarin YM, Le Goff F, Jeanneau S, Lescure FX, , A Self-Assessment Web-Based App to Assess Trends of the COVID-19 Pandemic in France: Observational Study., J Med Internet Res 2021 03; 23(3): e26182.
• 2021
  Funk AL, Hoen B, Vingdassalom I, Ryan C, Kadhel P, Schepers K, Gaete S, Tressières B, Fontanet A, , Reassessment of the risk of birth defects due to Zika virus in Guadeloupe, 2016., PLoS Negl Trop Dis 2021 Mar; 15(3): e0009048.
• 2021
  Fontanet A, Grant R, Greve-Isdahl M, Sridhar D, , Covid-19: Keeping schools as safe as possible., BMJ 2021 02; 372(): n524.
• 2021
  O'Driscoll M, Ribeiro Dos Santos G, Wang L, Cummings DAT, Azman AS, Paireau J, Fontanet A, Cauchemez S, Salje H, , Age-specific mortality and immunity patterns of SARS-CoV-2., Nature 2021 02; 590(7844): 140-145.
• 2021
  Rosado J, Pelleau S, Cockram C, Merkling SH, Nekkab N, Demeret C, Meola A, Kerneis S, Terrier B, Fafi-Kremer S, de Seze J, Bruel T, Dejardin F, Petres S, Longley R, Fontanet A, Backovic M, Mueller I, White MT, , Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study., Lancet Microbe 2021 Feb; 2(2): e60-e69.
• 2021
  Grant R, Fléchelles O, Tressières B, Dialo M, Elenga N, Mediamolle N, Mallard A, Hebert JC, Lachaume N, Couchy E, Hoen B, Fontanet A, , In utero Zika virus exposure and neurodevelopment at 24 months in toddlers normocephalic at birth: a cohort study., BMC Med 2021 Jan; 19(1): 12.
• 2021
  Bosetti P, Kiem CT, Yazdanpanah Y, Fontanet A, Lina B, Colizza V, Cauchemez S, , Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France., Euro Surveill 2021 01; 26(1): .
• 2021
  Anwar WA, El Gaafary M, Girgis SA, Rafik M, Hussein WM, Sos D, Mossad IM, Fontanet A, Temime L, , Hepatitis C virus infection and risk factors among patients and health-care workers of Ain Shams University hospitals, Cairo, Egypt., PLoS One 2021 ; 16(2): e0246836.
• 2021
  Galmiche S, Bruel T, Madec Y, Tondeur L, Grzelak L, Staropoli I, Cailleau I, Ungeheuer MN, Renaudat C, Fernandes Pellerin S, Hoen B, Schwartz O, Fontanet A, , Characteristics Associated with Olfactory and Taste Disorders in COVID-19., Neuroepidemiology 2021 ; 55(5): 381-386.
• 2020
  Galmiche S, Rahbe E, Fontanet A, Dinh A, Bénézit F, Lescure FX, Denis F, , Implementation of a Self-Triage Web Application for Suspected COVID-19 and Its Impact on Emergency Call Centers: Observational Study., J Med Internet Res 2020 11; 22(11): e22924.
• 2020
  Baay M, Lina B, Fontanet A, Marchant A, Saville M, Sabot P, Vandeputte J, Neels P, , Virology, epidemiology, immunology and vaccine development of SARS-CoV-2, update after nine months of pandemic., Biologicals 2020 Nov; (): .
• 2020
  N'Yetobouko Tabounie SJ, Kango SC, Bouscaillou J, Tricou V, Fontanet A, Kazanji M, Komas NP, , Fatal Outcome in a Hepatitis E Virus/Human Immunodeficiency Virus Co-Infected Malnourished Child in the Central African Republic., Infect Dis Rep 2020 Nov; 12(3): 82-86.
• 2020
  Pomar L, Lambert V, Madec Y, Vouga M, Pomar C, Matheus S, Fontanet A, Panchaud A, Carles G, Baud D, , Placental infection by Zika virus in French Guiana., Ultrasound Obstet Gynecol 2020 Nov; 56(5): 740-748.
• 2020
  Cauchemez S, Kiem CT, Paireau J, Rolland P, Fontanet A, , Lockdown impact on COVID-19 epidemics in regions across metropolitan France., Lancet 2020 10; 396(10257): 1068-1069.
• 2020
  Fontanet A, Cauchemez S, , COVID-19 herd immunity: where are we?, Nat Rev Immunol 2020 10; 20(10): 583-584.
• 2020
  Grzelak L, Temmam S, Planchais C, Demeret C, Tondeur L, Huon C, Guivel-Benhassine F, Staropoli I, Chazal M, Dufloo J, Planas D, Buchrieser J, Rajah MM, Robinot R, Porrot F, Albert M, Chen KY, Crescenzo-Chaigne B, Donati F, Anna F, Souque P, Gransagne M, Bellalou J, Nowakowski M, Backovic M, Bouadma L, Le Fevre L, Le Hingrat Q, Descamps D, Pourbaix A, Laouénan C, Ghosn J, Yazdanpanah Y, Besombes C, Jolly N, Pellerin-Fernandes S, Cheny O, Ungeheuer MN, Mellon G, Morel P, Rolland S, Rey FA, Behillil S, Enouf V, Lemaitre A, Créach MA, Petres S, Escriou N, Charneau P, Fontanet A, Hoen B, Bruel T, Eloit M, Mouquet H, Schwartz O, van der Werf S, , A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations., Sci Transl Med 2020 09; 12(559): .
• 2020
  Fafi-Kremer S, Bruel T, Madec Y, Grant R, Tondeur L, Grzelak L, Staropoli I, Anna F, Souque P, Fernandes-Pellerin S, Jolly N, Renaudat C, Ungeheuer MN, Schmidt-Mutter C, Collongues N, Bolle A, Velay A, Lefebvre N, Mielcarek M, Meyer N, Rey D, Charneau P, Hoen B, De Seze J, Schwartz O, Fontanet A, , Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France., EBioMedicine 2020 Sep; 59(): 102915.
• 2020
  Vallès X, Stenseth NC, Demeure C, Horby P, Mead PS, Cabanillas O, Ratsitorahina M, Rajerison M, Andrianaivoarimanana V, Ramasindrazana B, Pizarro-Cerda J, Scholz HC, Girod R, Hinnebusch BJ, Vigan-Womas I, Fontanet A, Wagner DM, Telfer S, Yazdanpanah Y, Tortosa P, Carrara G, Deuve J, Belmain SR, D'Ortenzio E, Baril L, , Human plague: An old scourge that needs new answers., PLoS Negl Trop Dis 2020 08; 14(8): e0008251.
• 2020
  Salje H, Tran Kiem C, Lefrancq N, Courtejoie N, Bosetti P, Paireau J, Andronico A, Hozé N, Richet J, Dubost CL, Le Strat Y, Lessler J, Levy-Bruhl D, Fontanet A, Opatowski L, Boelle PY, Cauchemez S, , Estimating the burden of SARS-CoV-2 in France., Science 2020 07; 369(6500): 208-211.
• 2020
  Besombes C, Njouom R, Paireau J, Lachenal G, Texier G, Tejiokem M, Cauchemez S, Pépin J, Fontanet A, , The epidemiology of hepatitis delta virus infection in Cameroon., Gut 2020 07; 69(7): 1294-1300.
• 2020
  Baay M, Lina B, Fontanet A, Marchant A, Saville M, Sabot P, Duclos P, Vandeputte J, Neels P, , SARS-CoV-2: Virology, epidemiology, immunology and vaccine development., Biologicals 2020 Jul; 66(): 35-40.
• 2020
  Denis F, Galmiche S, Dinh A, Fontanet A, Scherpereel A, Benezit F, Lescure FX, , Epidemiological Observations on the Association Between Anosmia and COVID-19 Infection: Analysis of Data From a Self-Assessment Web Application., J Med Internet Res 2020 06; 22(6): e19855.
• 2020
  Salam AP, Raberahona M, Andriantsalama P, Read L, Andrianarintsiferantsoa F, Razafinambinintsoa T, Rakotomalala R, Hasiniatsy RNE, Razafimandimby D, Castle L, Funk A, Mangahasimbola RT, Renaud B, Bertherat E, Lovering A, Heraud JM, Andrianaivoarimanana V, Frédérique R, Razanajatovo N, Baril L, Fontanet A, Rajerison M, Horby P, Randria M, Randremanana R, , Factors Influencing Atypical Clinical Presentations during the 2017 Madagascar Pneumonic Plague Outbreak: A Prospective Cohort Study., Am J Trop Med Hyg 2020 06; 102(6): 1309-1315.
• 2020
  Ramassamy JL, Tortevoye P, Ntab B, Seve B, Carles G, Gaquière D, Madec Y, Fontanet A, Gessain A, , Adult T-cell leukemia/lymphoma incidence rate in French Guiana: a prospective cohort of women infected with HTLV-1., Blood Adv 2020 05; 4(9): 2044-2048.
• 2019
  Laurence Baril, Xavier Vallès , Nils Christian Stenseth, Minoarisoa Rajerison, Maherisoa Ratsitorahina, Javier Pizarro-Cerdá, Christian Demeure, Steve Belmain, Holger Scholz, Romain Girod, Joseph Hinnebusch, Ines Vigan-Womas, Eric Bertherat, Arnaud Fontanet, Yazdan Yazadanpanah, Guia Carrara, Jane Deuve, Eric D'ortenzio, Jose Oswaldo Cabanillas Angulo, Paul Mead, Peter W Horby, Can we make human plague history? A call to action, BMJ Global Health 2019;4:e001984. doi:10.1136/ bmjgh-2019-001984.
• 2019
  Hoen B, Carpentier M, Gaete S, Tressières B, Herrmann-Storck C, Vingadassalom I, Huc-Anaïs P, Funk AL, Fontanet A, de Lamballerie X, , Kinetics of Anti-Zika Virus Antibodies after Acute Infection in Pregnant Women., J Clin Microbiol 2019 11; 57(11): .
• 2019
  Besombes C, Gonofio E, Konamna X, Selekon B, Grant R, Gessain A, Berthet N, Manuguerra JC, Fontanet A, Nakouné E, , Intrafamily Transmission of Monkeypox Virus, Central African Republic, 2018., Emerg Infect Dis 2019 08; 25(8): 1602-1604.
• 2019
  Bernard-Stoecklin S, Nikolay B, Assiri A, Bin Saeed AA, Ben Embarek PK, El Bushra H, Ki M, Malik MR, Fontanet A, Cauchemez S, Van Kerkhove MD, , Comparative Analysis of Eleven Healthcare-Associated Outbreaks of Middle East Respiratory Syndrome Coronavirus (Mers-Cov) from 2015 to 2017., Sci Rep 2019 05; 9(1): 7385.
• 2019
  Baril L, Vallès X, Stenseth NC, Rajerison M, Ratsitorahina M, Pizarro-Cerdá J, Demeure C, Belmain S, Scholz H, Girod R, Hinnebusch J, Vigan-Womas I, Bertherat E, Fontanet A, Yazadanpanah Y, Carrara G, Deuve J, D'ortenzio E, Angulo JOC, Mead P, Horby PW, , Can we make human plague history? A call to action., BMJ Glob Health 2019 ; 4(6): e001984.
• 2019
  Goldschmidt-Clermont PJ, Lemonne JR, Fontanet A, Stevenson M, , Virus Cooperation, ZIKV Viremia and in Utero Fetus Infection., Women Health Care Issues 2019 ; 2(2): .
• 2018
  Djuicy DD, Mouinga-Ondémé A, Cassar O, Ramassamy JL, Idam Mamimandjiami A, Bikangui R, Fontanet A, Gessain A, , Risk factors for HTLV-1 infection in Central Africa: A rural population-based survey in Gabon., PLoS Negl Trop Dis 2018 10; 12(10): e0006832.
• 2018
  El Kassas M, Funk AL, Abd El Latif Y, Vasiliu A, Sherief A, Shimakawa Y, Youssef N, El Tahan A, Elbadry M, Farid AM, El Shazly Y, Doss W, Esmat G, Fontanet A, , Letter: concordance of SVR4 and SVR12 following direct-acting anti-viral treatment in Egypt., Aliment Pharmacol Ther 2018 Jun; 47(11): 1564-1566.
• 2018
  Seck A, Ndiaye F, Maylin S, Ndiaye B, Simon F, Funk AL, Fontanet A, Takahashi K, Akbar SMF, Mishiro S, Bercion R, Vray M, Shimakawa Y, , Poor Sensitivity of Commercial Rapid Diagnostic Tests for Hepatitis B e Antigen in Senegal, West Africa., Am J Trop Med Hyg 2018 Aug; 99(2): 428-434.
• 2018
  Depoux A, Philibert A, Rabier S, Philippe HJ, Fontanet A, Flahault A, A multi-faceted pandemic: a review of the state of knowledge on the Zika virus, Public Health Rev 2018;39:10.
• 2018
  Njouom R, Siffert I, Texier G, Lachenal G, Tejiokem MC, Pépin J, Fontanet A, The burden of hepatitis C virus in Cameroon: Spatial epidemiology and historical perspective, J. Viral Hepat. 2018 08;25(8):959-968.
• 2018
  Llibre A, Shimakawa Y, Mottez E, Ainsworth S, Buivan TP, Firth R, Harrison E, Rosenberg AR, Meritet JF, Fontanet A, Castan P, Madejón A, Laverick M, Glass A, Viana R, Pol S, McClure CP, Irving WL, Miele G, Albert ML, Duffy D, , Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus., Gut 2018 Nov; 67(11): 2017-2024.
• 2018
  Hoen B, Schaub B, Funk AL, Ardillon V, Boullard M, Cabié A, Callier C, Carles G, Cassadou S, Césaire R, Douine M, Herrmann-Storck C, Kadhel P, Laouénan C, Madec Y, Monthieux A, Nacher M, Najioullah F, Rousset D, Ryan C, Schepers K, Stegmann-Planchard S, Tressières B, Voluménie JL, Yassinguezo S, Janky E, Fontanet A, Pregnancy Outcomes after ZIKV Infection in French Territories in the Americas, N. Engl. J. Med. 2018 03;378(11):985-994.
• 2018
  Rivoisy C, Vena A, Schaeffer L, Charlier C, Fontanet A, Delahaye F, Bouza E, Lortholary O, Munoz P, Lefort A, , Prosthetic Valve Candida spp. Endocarditis: New Insights Into Long-term Prognosis-The ESCAPE Study, Clin. Infect. Dis. 2018 Mar;66(6):825-832.
• 2018
  Tavares M, Carvalho AC, Almeida JP, Andrade P, São-Simão R, Soares P, Alves C, Pinto R, Fontanet A, Watier L, Implementation and impact of an audit and feedback antimicrobial stewardship intervention in the orthopaedics department of a tertiary-care hospital: a controlled interrupted time series study, Int. J. Antimicrob. Agents 2018 Jun;51(6):925-931.
• 2017
  Andronico A, Dorléans F, Fergé JL, Salje H, Ghawché F, Signate A, Daudens-Vaysse E, Baudouin L, Dub T, Aubry M, Cao-Lormeau VM, Ledrans M, Noel H, Mallet HP, Fontanet A, Cabié A, Cauchemez S, , Real-Time Assessment of Health-Care Requirements During the Zika Virus Epidemic in Martinique., Am J Epidemiol 2017 Nov; 186(10): 1194-1203.
• 2017
  Filomena A, Göpfert JC, Duffy D, Pol S, Abdel-Hamid M, Esmat G, Fontanet A, Albert ML, Joos TO, Schneiderhan-Marra N, Study of the Humoral Immune Response towards HCV Genotype 4 Using a Bead-Based Multiplex Serological Assay, High Throughput 2017 Oct;6(4).
• 2017
  Duffy D, Mottez E, Ainsworth S, Buivan TP, Baudin A, Vray M, Reed B, Fontanet A, Rohel A, Petrov-Sanchez V, Abel L, Theodorou I, Miele G, Pol S, Albert ML, An in vitro diagnostic certified point of care single nucleotide test for IL28B polymorphisms, PLoS ONE 2017;12(9):e0183084.
• 2017
  Dub T, Fontanet A, Zika virus and Guillain-Barré syndrome, Rev. Neurol. (Paris) 2017 06;173(6):361-363.
• 2017
  Vandelannoote K, Meehan CJ, Eddyani M, Affolabi D, Phanzu DM, Eyangoh S, Jordaens K, Portaels F, Mangas K, Seemann T, Marsollier L, Marion E, Chauty A, Landier J, Fontanet A, Leirs H, Stinear TP, de Jong BC, Multiple Introductions and Recent Spread of the Emerging Human Pathogen Mycobacterium ulcerans across Africa, Genome Biol Evol 2017 03;9(3):414-426.
• 2017
  Filippone C, de Oliveira F, Betsem E, Schaeffer L, Fontanet A, Lemée V, Gessain A, Plantier JC, Simian Immunodeficiency Virus seroreactivity in inhabitants from rural Cameroon frequently in contact with non-human primates, Virology 2017 03;503:76-82.
• 2016
  Maïnassara HB, Oumarou GI, Issaka B, Sidiki A, Idi I, Pelat JM, Fontanet A, Mueller JE, Evaluation of response strategies against epidemics due to Neisseria meningitidis C in Niger, Trop. Med. Int. Health 2017 02;22(2):196-204.
• 2016
  Maïnassara HB, Paireau J, Idi I, Jusot JF, Moulia Pelat JP, Ouwe Missi Oukem-Boyer O, Fontanet A, Mueller JE, Serogroup-Specific Characteristics of Localized Meningococcal Meningitis Epidemics in Niger 2002-2012 and 2015: Analysis of Health Center Level Surveillance Data, PLoS ONE 2016;11(9):e0163110.
• 2016
  Cauchemez S, Besnard M, Garel C, Fontanet A, Mallet HP, Could clinical symptoms be a predictor of complications in Zika virus infection? – Authors’ reply, Lancet 2016 Jul;388(10042):338-339.
• 2016
  Fontanet A, Cao-Lormeau VM, Dub T, Mallet HP, Ghawché F, Association between Guillain-Barré syndrome and Zika virus infection – Authors’ reply, Lancet 2016 Jun;387(10038):2600.
• 2016
  Kandeel A, Genedy M, El-Refai S, Funk AL, Fontanet A, Talaat M, The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment, Liver Int. 2016 Jun;.
• 2016
  Cauchemez S, Besnard M, Bompard P, Dub T, Guillemette-Artur P, Eyrolle-Guignot D, Salje H, Van Kerkhove MD, Abadie V, Garel C, Fontanet A, Mallet HP, Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study, Lancet 2016 May;387(10033):2125-2132.
• 2016
  Cao-Lormeau VM, Blake A, Mons S, Lastère S, Roche C, Vanhomwegen J, Dub T, Baudouin L, Teissier A, Larre P, Vial AL, Decam C, Choumet V, Halstead SK, Willison HJ, Musset L, Manuguerra JC, Despres P, Fournier E, Mallet HP, Musso D, Fontanet A, Neil J, Ghawché F, Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study, Lancet 2016 Apr;387(10027):1531-9.
• 2015
  Riou J, Aït Ahmed M, Blake A, Vozlinsky S, Brichler S, Eholié S, Boëlle PY, Fontanet A, , Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta-analysis, J. Viral Hepat. 2016 Apr;23(4):244-55.
• 2015
  Landier J, Constantin de Magny G, Garchitorena A, Guégan JF, Gaudart J, Marsollier L, Le Gall P, Giles-Vernick T, Eyangoh S, Fontanet A, Texier G, Seasonal Patterns of Buruli Ulcer Incidence, Central Africa, 2002-2012, Emerging Infect. Dis. 2015 Aug;21(8):1414-7.
• 2015
  Maïnassara HB, Paireau J, Idi I, Pelat JP, Oukem-Boyer OO, Fontanet A, Mueller JE, Response Strategies against Meningitis Epidemics after Elimination of Serogroup A Meningococci, Niger, Emerging Infect. Dis. 2015 Aug;21(8):1322-9.
• 2015
  Pedergnana V, Abdel-Hamid M, Guergnon J, Theodorou I, Fontanet A, Abel L, Cobat A, Refined association of melanoma differentiation-associated gene 5 variants with spontaneous hepatitis C virus clearance in Egypt, Hepatology 2015 Jun;.
• 2015
  Okasha O, Munier A, Delarocque-Astagneau E, El Houssinie M, Rafik M, Bassim H, Hamid MA, Mohamed MK, Fontanet A, Hepatitis C virus infection and risk factors in health-care workers at Ain Shams University Hospitals, Cairo, Egypt, East. Mediterr. Health J. 2015 Mar;21(3):199-212.
• 2015
  Obach D, Yazdanpanah Y, Esmat G, Avihingsanon A, Dewedar S, Durier N, Attia A, Anwar WA, Cousien A, Tangkijvanich P, Eholié SP, Doss W, Mostafa A, Fontanet A, Mohamed MK, Deuffic-Burban S, How to optimize hepatitis C virus treatment impact on life years saved in resource-constrained countries, Hepatology 2015 Jul;62(1):31-9.
• 2015
  Filippone C, Betsem E, Tortevoye P, Cassar O, Bassot S, Froment A, Fontanet A, Gessain A, A Severe Bite From a Nonhuman Primate Is a Major Risk Factor for HTLV-1 Infection in Hunters From Central Africa, Clin. Infect. Dis. 2015 Jun;60(11):1667-76.
• 2015
  Sultanik P, Mallet V, Lagaye S, Casrouge A, Dorival C, Barthe Y, Fontaine H, Hézode C, Mottez E, Bronowicki JP, Carrat F, Theodorou I, Abel L, Gayat E, Fontanet A, Pol S, Albert ML, , Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy, Liver Int. 2015 Jul;35(7):1833-44.
• 2015
  Vayssier-Taussat M, Cosson JF, Degeilh B, Eloit M, Fontanet A, Moutailler S, Raoult D, Sellal E, Ungeheuer MN, Zylbermann P, How a multidisciplinary ‘One Health’ approach can combat the tick-borne pathogen threat in Europe, Future Microbiol 2015;10(5):809-18.
• 2014
  Breban R, Fontanet A, Feasible HCV targets in Egypt – authors’ reply, Lancet Glob Health 2014 Dec;2(12):e688.
• 2014
  Carolan K, Garchitorena A, García-Peña GE, Morris A, Landier J, Fontanet A, Le Gall P, Texier G, Marsollier L, Gozlan RE, Eyangoh S, Lo Seen D, Guégan JF, Topography and land cover of watersheds predicts the distribution of the environmental pathogen Mycobacterium ulcerans in aquatic insects, PLoS Negl Trop Dis 2014 Nov;8(11):e3298.
• 2014
  Landier J, Fontanet A, Texier G, Defining and targeting high-risk populations in Buruli ulcer, Lancet Glob Health 2014 Nov;2(11):e629.
• 2014
  Mohsen A, Bernier A, LeFouler L, Delarocque-Astagneau E, El-Daly M, El-Kafrawy S, El-Mango S, Abdel-Hamid M, Gadallah M, Esmat G, Mohamed MK, Fontanet A, Hepatitis C virus acquisition among Egyptians: analysis of a 10-year surveillance of acute hepatitis C, Trop. Med. Int. Health 2015 Jan;20(1):89-97.
• 2014
  Laird ME, Mohsen A, Duffy D, Mamdouh R, LeFouler L, Casrouge A, El-Daly M, Rafik M, Abdel-Hamid M, Soulier A, Pawlotsky JM, Hézode C, Rosa I, Renard P, Mohamed MK, Bonnard P, Izopet J, Mallet V, Pol S, Albert ML, Fontanet A, , Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection., J. Hepatol. 2014 Oct; 61(4): 770-6.
• 2014
  Landier J, Gaudart J, Carolan K, Lo Seen D, Guégan JF, Eyangoh S, Fontanet A, Texier G, Spatio-temporal patterns and landscape-associated risk of Buruli ulcer in Akonolinga, Cameroon, PLoS Negl Trop Dis 2014 Sep;8(9):e3123.
• 2014
  Breban R, Arafa N, Leroy S, Mostafa A, Bakr I, Tondeur L, Abdel-Hamid M, Doss W, Esmat G, Mohamed MK, Fontanet A, Effect of preventive and curative interventions on hepatitis C virus transmission in Egypt (ANRS 1211): a modelling study, Lancet Glob Health 2014 Sep;2(9):e541-e549.
• 2014
  Bonnard P, Elsharkawy A, Zalata K, Delarocque-Astagneau E, Biard L, Le Fouler L, Hassan AB, Abdel-Hamid M, El-Daly M, Gamal ME, El Kassas M, Bedossa P, Carrat F, Fontanet A, Esmat G, Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in Egypt, J. Viral Hepat. 2015 Mar;22(3):245-53.
• 2014
  Pommelet V, Vincent QB, Ardant MF, Adeye A, Tanase A, Tondeur L, Rega A, Landier J, Marion E, Alcaïs A, Marsollier L, Fontanet A, Chauty A, Findings in patients from Benin with osteomyelitis and polymerase chain reaction-confirmed Mycobacterium ulcerans infection, Clin. Infect. Dis. 2014 Nov;59(9):1256-64.
• 2014
  Rachas A, Nakouné E, Bouscaillou J, Paireau J, Selekon B, Senekian D, Fontanet A, Kazanji M, Timeliness of yellow fever surveillance, Central African Republic, Emerging Infect. Dis. 2014 Jun;20(6):1004-8.
• 2014
  Paireau J, Maïnassara HB, Jusot JF, Collard JM, Idi I, Moulia-Pelat JP, Mueller JE, Fontanet A, Spatio-temporal factors associated with meningococcal meningitis annual incidence at the health centre level in Niger, 2004-2010, PLoS Negl Trop Dis 2014 May;8(5):e2899.
• 2014
  Garchitorena A, Roche B, Kamgang R, Ossomba J, Babonneau J, Landier J, Fontanet A, Flahault A, Eyangoh S, Guégan JF, Marsollier L, Mycobacterium ulcerans ecological dynamics and its association with freshwater ecosystems and aquatic communities: results from a 12-month environmental survey in Cameroon, PLoS Negl Trop Dis 2014 May;8(5):e2879.
• 2014
  Betsem E, Cassar O, Afonso PV, Fontanet A, Froment A, Gessain A, Epidemiology and genetic variability of HHV-8/KSHV in Pygmy and Bantu populations in Cameroon, PLoS Negl Trop Dis 2014 May;8(5):e2851.
• 2014
  Cousien A, Obach D, Deuffic-Burban S, Mostafa A, Esmat G, Canva V, El Kassas M, El-Sayed M, Anwar WA, Fontanet A, Mohamed MK, Yazdanpanah Y, Is expert opinion reliable when estimating transition probabilities? The case of HCV-related cirrhosis in Egypt, BMC Med Res Methodol 2014;14:39.
• 2014
  Borand L, Madec Y, Laureillard D, Chou M, Marcy O, Pheng P, Prak N, Kim C, Lak KK, Hak C, Dim B, Nerrienet E, Fontanet A, Sok T, Goldfeld AE, Blanc FX, Taburet AM, Plasma concentrations, efficacy and safety of efavirenz in HIV-infected adults treated for tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA trial), PLoS ONE 2014;9(3):e90350.
• 2014
  Duffy D, Mamdouh R, Laird M, Soneson C, Le Fouler L, El-Daly M, Casrouge A, Decalf J, Abbas A, Eldin NS, Fontes M, Abdel-Hamid M, Mohamed MK, Rafik M, Fontanet A, Albert ML, The ABCs of viral hepatitis that define biomarker signatures of acute viral hepatitis, Hepatology 2014 Apr;59(4):1273-82.
• 2014
  Viladés C, Escoté X, López-Dupla M, Martinez E, Domingo P, Asensi V, Leal M, Peraire J, Inza MI, Arnedo M, Gutiérrez M, Valle-Garay E, Ferrando-Martinez S, Olona M, Alba V, Sirvent JJ, Gatell JM, Vidal F, , Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS), J. Antimicrob. Chemother. 2014 Jun;69(6):1653-9.
• 2014
  Obach D, Deuffic-Burban S, Esmat G, Anwar WA, Dewedar S, Canva V, Cousien A, Doss W, Mostafa A, Pol S, Buti M, Siebert U, Fontanet A, Mohamed MK, Yazdanpanah Y, Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of Egypt, Clin. Infect. Dis. 2014 Apr;58(8):1064-71.
• 2014
  Féray C, Bouscaillou J, Falissard B, Mohamed MK, Arafa N, Bakr I, El-Hoseiny M, Daly ME, El-Kafrawy S, Plancoulaine S, Abdel-Hamid M, Thiers V, Fontanet A, A novel method to identify routes of hepatitis C virus transmission, PLoS ONE 2014;9(1):e86098.
• 2014
  Penot P, Héma A, Bado G, Kaboré F, Soré I, Sombié D, Traoré JR, Guiard-Schmid JB, Fontanet A, Slama L, Bruno Sawadogo A, Laurent C, The vulnerability of men to virologic failure during antiretroviral therapy in a public routine clinic in Burkina Faso, J Int AIDS Soc 2014;17:18646.
• 2013
  Thursz M, Fontanet A, HCV transmission in industrialized countries and resource-constrained areas, Nat Rev Gastroenterol Hepatol 2014 Jan;11(1):28-35.
• 2013
  Breban R, Doss W, Esmat G, Elsayed M, Hellard M, Ayscue P, Albert M, Fontanet A, Mohamed MK, Quantifying current hepatitis C virus incidence in Egypt – Response to letter by Miller and Abu-Raddad, J. Viral Hepat. 2013 Sep;20(9):668.
• 2013
  Breban R, Riou J, Fontanet A, Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk, Lancet 2013 Aug;382(9893):694-9.
• 2013
  Guery B, Poissy J, el Mansouf L, Séjourné C, Ettahar N, Lemaire X, Vuotto F, Goffard A, Behillil S, Enouf V, Caro V, Mailles A, Che D, Manuguerra JC, Mathieu D, Fontanet A, van der Werf S, , Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission, Lancet 2013 Jun;381(9885):2265-72.
• 2013
  Ragab D, Laird M, Duffy D, Casrouge A, Mamdouh R, Abass A, Shenawy DE, Shebl AM, Elkashef WF, Zalata KR, Kamal M, Esmat G, Bonnard P, Fontanet A, Rafik M, Albert ML, CXCL10 antagonism and plasma sDPPIV correlate with increasing liver disease in chronic HCV genotype 4 infected patients, Cytokine 2013 Aug;63(2):105-12.
• 2013
  Munier A, Marzouk D, Abravanel F, El-Daly M, Taylor S, Mamdouh R, Eldin WS, El-Arab HE, Sos DG, Momen M, Okasha O, Le Fouler L, El-Hosini M, Izopet J, Rafik M, Albert M, Abdel-Hamid M, Mohamed MK, Delarocque-Astagneau E, Fontanet A, Frequent transient hepatitis C viremia without seroconversion among healthcare workers in Cairo, Egypt, PLoS ONE 2013;8(2):e57835.
• 2013
  Bouscaillou J, Komas N, Tricou V, Nakouné E, Sélékon B, Fontanet A, Kazanji M, Imported hepatitis e virus, central african republic, 2011, Emerging Infect. Dis. 2013 Feb;19(2):335-7.
• 2013
  Hanna M, Minga A, Fao P, Borand L, Diouf A, Mben JM, Gad RR, Anglaret X, Bazin B, Chene G, , Development of a checklist of quality indicators for clinical trials in resource-limited countries: the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) experience, Clin Trials 2013 Apr;10(2):300-18.
• 2012
  Gallego-Escuredo JM, Domingo P, Gutiérrez Mdel M, Mateo MG, Cabeza MC, Fontanet A, Vidal F, Domingo JC, Giralt M, Villarroya F, Reduced levels of serum FGF19 and impaired expression of receptors for endocrine FGFs in adipose tissue from HIV-infected patients, J. Acquir. Immune Defic. Syndr. 2012 Dec;61(5):527-34.
• 2012
  Paireau J, Tuan NH, Lefrançois R, Buckwalter MR, Nghia ND, Hien NT, Lortholary O, Poirée S, Manuguerra JC, Gessain A, Albert ML, Brey PT, Nga PT, Fontanet A, Litchi-associated acute encephalitis in children, Northern Vietnam, 2004-2009, Emerging Infect. Dis. 2012 Nov;18(11):1817-24.
• 2012
  Breban R, Doss W, Esmat G, Elsayed M, Hellard M, Ayscue P, Albert M, Fontanet A, Mohamed MK, Towards realistic estimates of HCV incidence in Egypt, J. Viral Hepat. 2013 Apr;20(4):294-6.
• 2012
  Pedergnana V, Abdel-Hamid M, Guergnon J, Mohsen A, Le Fouler L, Theodorou I, Mohamed MK, Fontanet A, Plancoulaine S, Abel L, Analysis of IL28B variants in an Egyptian population defines the 20 kilobases minimal region involved in spontaneous clearance of hepatitis C virus, PLoS ONE 2012;7(6):e38578.
• 2012
  Lefort A, Chartier L, Sendid B, Wolff M, Mainardi JL, Podglajen I, Desnos-Ollivier M, Fontanet A, Bretagne S, Lortholary O, , , Diagnosis, management and outcome of Candida endocarditis., Clin Microbiol Infect 2012 Apr; 18(4): E99-E109.
• 2012
  Domingo P, Guardiola JM, Salazar J, Torres F, Mateo MG, Pacho C, Del Mar Gutierrez M, Lamarca K, Fontanet A, Martin J, Muñoz J, Vidal F, Baiget M, Association of ITPA gene polymorphisms and the risk of ribavirin-induced anemia in HIV/hepatitis C virus (HCV)-coinfected patients receiving HCV combination therapy, Antimicrob. Agents Chemother. 2012 Jun;56(6):2987-93.
• 2012
  Guerra J, Garenne M, Mohamed MK, Fontanet A, HCV burden of infection in Egypt: results from a nationwide survey, J. Viral Hepat. 2012 Aug;19(8):560-7.
• 2012
  Delarocque-Astagneau E, Abravanel F, Moshen A, Le Fouler L, Gad RR, El-Daly M, Ibrahim EM, El-Aidy S, Lashin T, El-Hoseiny M, Izopet J, Mohamed MK, Fontanet A, Abdel Hamid M, Epidemiological and virological characteristics of symptomatic acute hepatitis E in Greater Cairo, Egypt, Clin. Microbiol. Infect. 2012 Oct;18(10):982-8.
• 2012
  Ceperuelo-Mallafré V, Escoté X, Viladés C, Peraire J, Domingo P, Solano E, Sirvent JJ, Pastor R, Tinahones F, Leal M, Richart C, Vendrell J, Vidal F, , Alba V, Aguilar A, Auguet T, Chacón MR, López-Dupla M, Megia A, Miranda M, Olona M, Saurí A, Vargas M, Velasco I, Veloso S, Fontanet A, Gutiérrez M, Mateo G, Muñoz J, Sambeat MA, Zinc alpha-2 glycoprotein is implicated in dyslipidaemia in HIV-1-infected patients treated with antiretroviral drugs, HIV Med. 2012 May;13(5):297-303.
• 2011
  Landier J, Boisier P, Fotso Piam F, Noumen-Djeunga B, Simé J, Wantong FG, Marsollier L, Fontanet A, Eyangoh S, Adequate wound care and use of bed nets as protective factors against Buruli Ulcer: results from a case control study in Cameroon, PLoS Negl Trop Dis 2011 Nov;5(11):e1392.
• 2011
  Werneke SW, Schilte C, Rohatgi A, Monte KJ, Michault A, Arenzana-Seisdedos F, Vanlandingham DL, Higgs S, Fontanet A, Albert ML, Lenschow DJ, ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation, PLoS Pathog. 2011 Oct;7(10):e1002322.
• 2011
  Guenin-Macé L, Carrette F, Asperti-Boursin F, Le Bon A, Caleechurn L, Di Bartolo V, Fontanet A, Bismuth G, Demangel C, , Mycolactone impairs T cell homing by suppressing microRNA control of L-selectin expression., Proc. Natl. Acad. Sci. U.S.A. 2011 Aug; 108(31): 12833-8.
• 2011
  Chartier L, Leng C, Sire JM, Le Minor O, Saman M, Bercion R, Rahalison L, Fontanet A, Germany Y, L'her P, Mayaud C, Vray M, Factors associated with negative direct sputum examination in Asian and African HIV-infected patients with tuberculosis (ANRS 1260), PLoS ONE 2011;6(6):e21212.
• 2011
  Buckwalter MR, Nga PT, Gouilh MA, Fiette L, Bureau JF, Laird ME, Buchrieser J, Ozden S, Cheval J, Eloit M, Manuguerra JC, Gessain A, Brey PT, Fontanet A, Albert ML, Identification of a novel neuropathogenic Theiler’s murine encephalomyelitis virus, J. Virol. 2011 Jul;85(14):6893-905.
• 2011
  Albert ML, Casrouge A, Chevaliez S, Hézode C, Rosa I, Renard P, Mallet V, Fontanet A, Pawlotsky JM, Pol S, Interferon induced protein 10 remains a useful biomarker of treatment failure in patients stratified for the interleukin-28B rs12979860 haplotype, Hepatology 2011 Apr;53(4):1410-1.
• 2011
  Vignier N, Esmat G, Elsharkawy A, Hassany M, Bonnard P, Delarocque-Astagneau E, Said M, Raafat R, El-Hoseiny M, Fontanet A, Mohamed MK, Vray M, Reproducibility of liver stiffness measurements in hepatitis C virus (HCV)-infected patients in Egypt, J. Viral Hepat. 2011 Jul;18(7):e358-65.
• 2011
  Landier J, Akonde A, Pizzocolo C, Haidara I, Drabo M, Pizarro L, Fontanet A, Katlama C, Madec Y, Switch to second-line ART in West African routine care: incidence and reasons for switching, AIDS Care 2011 Jan;23(1):75-8.
• 2010
  Casrouge A, Decalf J, Ahloulay M, Lababidi C, Mansour H, Vallet-Pichard A, Mallet V, Mottez E, Mapes J, Fontanet A, Pol S, Albert ML, Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV, J. Clin. Invest. 2011 Jan;121(1):308-17.
• 2010
  Vanhomwegen J, Kwara A, Martin M, Gillani FS, Fontanet A, Mutungi P, Crellin J, Obaro S, Gosciminski M, Carter EJ, Rastogi N, Impact of immigration on the molecular epidemiology of tuberculosis in Rhode Island, J. Clin. Microbiol. 2011 Mar;49(3):834-44.
• 2010
  Micol R, Tajahmady A, Lortholary O, Balkan S, Quillet C, Dousset JP, Chanroeun H, Madec Y, Fontanet A, Yazdanpanah Y, Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia, PLoS ONE 2010;5(11):e13856.
• 2010
  Wang W, Cavailler P, Ren P, Zhang J, Dong W, Yan H, Mardy S, Cailhol J, Buchy P, Sheng J, Fontanet A, Deubel V, Molecular monitoring of causative viruses in child acute respiratory infection in endemo-epidemic situations in Shanghai, J. Clin. Virol. 2010 Nov;49(3):211-8.
• 2010
  Juffroy O, Bugault F, Lambotte O, Landires I, Viard JP, Niel L, Fontanet A, Delfraissy JF, Thèze J, Chakrabarti LA, Dual mechanism of impairment of interleukin-7 (IL-7) responses in human immunodeficiency virus infection: decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway, J. Virol. 2010 Jan;84(1):96-108.
• 2009
  Paez Jimenez A, Mohamed MK, Eldin NS, Seif HA, El Aidi S, Sultan Y, Elsaid N, Rekacewicz C, El-Hoseiny M, El-Daly M, Abdel-Hamid M, Fontanet A, Injection drug use is a risk factor for HCV infection in urban Egypt, PLoS ONE 2009;4(9):e7193.
• 2009
  Micol R, Buchy P, Guerrier G, Duong V, Ferradini L, Dousset JP, Guerin PJ, Balkan S, Galimand J, Chanroeun H, Lortholary O, Rouzioux C, Fontanet A, Leruez-Ville M, Prevalence, risk factors, and impact on outcome of cytomegalovirus replication in serum of Cambodian HIV-infected patients (2004-2007), J. Acquir. Immune Defic. Syndr. 2009 Aug;51(4):486-91.
• 2009
  Paez Jimenez A, El-Din NS, El-Hoseiny M, El-Daly M, Abdel-Hamid M, El Aidi S, Sultan Y, El-Sayed N, Mohamed MK, Fontanet A, Community transmission of hepatitis B virus in Egypt: results from a case-control study in Greater Cairo, Int J Epidemiol 2009 Jun;38(3):757-65.
• 2009
  Madec Y, Szumilin E, Genevier C, Ferradini L, Balkan S, Pujades M, Fontanet A, Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries, AIDS 2009 Apr;23(7):853-61.
• 2009
  Martinez-Jéhanne V, du Merle L, Bernier-Fébreau C, Usein C, Gassama-Sow A, Wane AA, Gouali M, Damian M, Aïdara-Kane A, Germani Y, Fontanet A, Coddeville B, Guérardel Y, Le Bouguénec C, Role of deoxyribose catabolism in colonization of the murine intestine by pathogenic Escherichia coli strains, Infect. Immun. 2009 Apr;77(4):1442-50.
• 2008
  Le Minor O, Germani Y, Chartier L, Lan NH, Lan NT, Duc NH, Laureillard D, Fontanet A, Sar B, Saman M, Chan S, L'Her P, Mayaud C, Vray M, Predictors of pneumocystosis or tuberculosis in HIV-infected Asian patients with AFB smear-negative sputum pneumonia, J. Acquir. Immune Defic. Syndr. 2008 Aug;48(5):620-7.
• 2008
  Abdoul H, Mallet V, Pol S, Fontanet A, Serum alpha-fetoprotein predicts treatment outcome in chronic hepatitis C patients regardless of HCV genotype, PLoS ONE 2008 Jun;3(6):e2391.
• 2008
  Charlier C, Dromer F, Lévêque C, Chartier L, Cordoliani YS, Fontanet A, Launay O, Lortholary O, , Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era, PLoS ONE 2008;3(4):e1950.
• 2007
  Briand V, Bouchaud O, Tourret J, Behr C, Abgrall S, Ralaimazava P, Le Bras J, Fontanet A, Hospitalization criteria in imported falciparum malaria, J Travel Med 2007 Sep-Oct;14(5):306-11.
• 2007
  Micol R, Lortholary O, Sar B, Laureillard D, Ngeth C, Dousset JP, Chanroeun H, Ferradini L, Guerin PJ, Dromer F, Fontanet A, Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients, J. Acquir. Immune Defic. Syndr. 2007 Aug;45(5):555-9.
• 2007
  Fontanet A, [Cross-species transmission: last obstacle before pandemic], Transfus Clin Biol 2007 May;14(1):16-7.
• 2007
  Madec Y, Laureillard D, Pinoges L, Fernandez M, Prak N, Ngeth C, Moeung S, Song S, Balkan S, Ferradini L, Quillet C, Fontanet A, Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia, AIDS 2007 Jan;21(3):351-9.
• 2007
  Fontanet A, [Lessons from SARS], Presse Med 2007 Feb;36(2 Pt 2):299-302.
• 2007
  Males S, Gad RR, Esmat G, Abobakr H, Anwar M, Rekacewicz C, El Hoseiny M, Zalata K, Abdel-Hamid M, Bedossa P, Pol S, Mohamed MK, Fontanet A, Serum alpha-foetoprotein level predicts treatment outcome in chronic hepatitis C, Antivir. Ther. (Lond.) 2007;12(5):797-803.
• 2007
  Colle JH, Moreau JL, Fontanet A, Lambotte O, Delfraissy JF, Thèze J, The correlation between levels of IL-7Ralpha expression and responsiveness to IL-7 is lost in CD4 lymphocytes from HIV-infected patients, AIDS 2007 Jan;21(1):101-3.
• 2006
  Briand V, Buffet P, Genty S, Lacombe K, Godineau N, Salomon J, Vandemelbrouck E, Ralaimazava P, Goujon C, Matheron S, Fontanet A, Bouchaud O, Absence of efficacy of nonviable Lactobacillus acidophilus for the prevention of traveler’s diarrhea: a randomized, double-blind, controlled study, Clin. Infect. Dis. 2006 Nov;43(9):1170-5.
• 2006
  Colle JH, Moreau JL, Fontanet A, Lambotte O, Joussemet M, Jacod S, Delfraissy JF, Thèze J, Regulatory dysfunction of the interleukin-7 receptor in CD4 and CD8 lymphocytes from HIV-infected patients–effects of antiretroviral therapy, J. Acquir. Immune Defic. Syndr. 2006 Jul;42(3):277-85.
• 2006
  Bégaud E, Chartier L, Marechal V, Ipero J, Léal J, Versmisse P, Breton G, Fontanet A, Capoulade-Metay C, Fleury H, Barré-Sinoussi F, Scott-Algara D, Pancino G, Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans, Retrovirology 2006;3:35.
• 2006
  Sall AA, Ségéral O, Reynes JM, Lay S, Ouk V, Hak CR, Keo CL, Lefait RR, Delfraissy JF, Fontanet A, Immunosuppression and GB virus C-RNA detection among HIV-infected patients in Cambodia, AIDS 2006 May;20(8):1199-201.
• 2006
  Tran HK, Chartier L, Troung LX, Nguyen NN, Fontanet A, Barré-Sinoussi FE, Pancino G, Scott-Algara D, Systemic immune activation in HIV-1-exposed uninfected Vietnamese intravascular drug users, AIDS Res. Hum. Retroviruses 2006 Mar;22(3):255-61.
• 2005
  Lortholary O, Fontanet A, Mémain N, Martin A, Sitbon K, Dromer F,, Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France, AIDS 2005 Jul;19(10):1043-9.
• 2005
  Fontanet AL, Houzé S, Keundjian A, Schiemann R, Ralaimazava P, Durand R, Cha O, Coulaud JP, Le Bras J, Bouchaud O, Efficacy of antimalarial chemoprophylaxis among French residents travelling to Africa, Trans. R. Soc. Trop. Med. Hyg. 2005 Feb;99(2):91-100.
• 2004
  Beq S, Fontanet A, Theze J, Colle JH, IL-7 and Flt-3L plasma levels are increased during highly active antiretroviral therapy-associated IL-2 therapy, AIDS 2004 Oct;18(15):2089-91.
• 2004
  Beq S, Rannou MT, Fontanet A, Delfraissy JF, Thèze J, Colle JH, HIV infection: pre-highly active antiretroviral therapy IL-7 plasma levels correlate with long-term CD4 cell count increase after treatment, AIDS 2004 Feb;18(3):563-5.
• 2003
  Truong LX, Luong TT, Scott-Algara D, Versmisse P, David A, Perez-Bercoff D, Nguyen NV, Tran HK, Cao CT, Fontanet A, Follézou JY, Theodorou I, Barré-Sinoussi F, Pancino G, CD4 cell and CD8 cell-mediated resistance to HIV-1 infection in exposed uninfected intravascular drug users in Vietnam, AIDS 2003 Jul;17(10):1425-34.